BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9132015)

  • 1. A Gs-selective analog of the receptor-mimetic peptide mastoparan binds to Gs alpha in a kinked helical conformation.
    Sukumar M; Ross EM; Higashijima T
    Biochemistry; 1997 Mar; 36(12):3632-9. PubMed ID: 9132015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-bound conformation of mastoparan-X: heteronuclear multidimensional transferred nuclear overhauser effect analysis of peptide uniformly enriched with 13C and 15N.
    Kusunoki H; Wakamatsu K; Sato K; Miyazawa T; Kohno T
    Biochemistry; 1998 Apr; 37(14):4782-90. PubMed ID: 9537994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-bound conformation of mastoparan-X, a receptor-mimetic peptide.
    Sukumar M; Higashijima T
    J Biol Chem; 1992 Oct; 267(30):21421-4. PubMed ID: 1400455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastoparan inhibits beta-adrenoceptor-G(s) signaling by changing the localization of Galpha(s) in lipid rafts.
    Sugama J; Yu JZ; Rasenick MM; Nakahata N
    Cell Signal; 2007 Nov; 19(11):2247-54. PubMed ID: 17692506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S111N mutation in the helical domain of human Gs(alpha) reduces its GDP/GTP exchange rate.
    Brito M; Guzmán L; Romo X; Soto X; Hinrichs MV; Olate J
    J Cell Biochem; 2002; 85(3):615-20. PubMed ID: 11968001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-bound conformation of mastoparan-X, a G-protein-activating peptide.
    Wakamatsu K; Okada A; Miyazawa T; Ohya M; Higashijima T
    Biochemistry; 1992 Jun; 31(24):5654-60. PubMed ID: 1610813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational studies on a synthetic C-terminal fragment of the alpha subunit of G(S) proteins.
    Albrizio S; D'Ursi A; Fattorusso C; Galoppini C; Greco G; Mazzoni MR; Novellino E; Rovero P
    Biopolymers; 2000 Sep; 54(3):186-94. PubMed ID: 10861380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
    Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
    Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for two distinct Mg2+ binding sites in G(s alpha) and G(i alpha1) proteins.
    Malarkey CS; Wang G; Ballicora MA; Mota de Freitas DE
    Biochem Biophys Res Commun; 2008 Aug; 372(4):866-9. PubMed ID: 18539137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the mastoparan-binding site on G proteins. Cross-linking of [125I-Tyr3,Cys11]mastoparan to Go.
    Higashijima T; Ross EM
    J Biol Chem; 1991 Jul; 266(19):12655-61. PubMed ID: 1905730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galphas protein C-terminal alpha-helix at the interface: does the plasma membrane play a critical role in the Galphas protein functionality?
    Albrizio S; Caliendo G; D'Errico G; Novellino E; Rovero P; D'Ursi AM
    J Pept Sci; 2005 Oct; 11(10):617-26. PubMed ID: 15898053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of a 12-residue analogue of mastoparan and of mastoparan X.
    Faerman CH; Ripoll DR
    Proteins; 1992 Feb; 12(2):111-6. PubMed ID: 1603800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization and topology of the second potential membrane anchor region in the thromboxane A2 synthase amino-terminal domain.
    Ruan KH; Li D; Ji J; Lin YZ; Gao X
    Biochemistry; 1998 Jan; 37(3):822-30. PubMed ID: 9454571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of mastoparan from Polistes jadwagae at 1.2 A resolution.
    Liu S; Wang F; Tang L; Gui W; Cao P; Liu X; Poon AW; Shaw PC; Jiang T
    J Struct Biol; 2007 Oct; 160(1):28-34. PubMed ID: 17656112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists.
    Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW
    Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
    Mistry R; Dowling MR; Challiss RA
    Br J Pharmacol; 2005 Feb; 144(4):566-75. PubMed ID: 15655507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
    Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
    Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance studies on conformation and stability of mastoparan in methanol.
    Miura Y
    J Pept Sci; 2021 Sep; 27(9):e3338. PubMed ID: 33973297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanine nucleotide exchange-independent activation of Gs protein by beta2-adrenoceptor.
    Ugur O; Oner SS; Molinari P; Ambrosio C; Sayar K; Onaran HO
    Mol Pharmacol; 2005 Sep; 68(3):720-8. PubMed ID: 15933218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation of a Cdc42/Rac interactive binding peptide in complex with Cdc42 and analysis of the binding interface.
    Stevens WK; Vranken W; Goudreau N; Xiang H; Xu P; Ni F
    Biochemistry; 1999 May; 38(19):5968-75. PubMed ID: 10320322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.